Wednesday, 3 June 2026
Thrombus risk with catheter kit, Ambulance use in aged care, Tenecteplase trial for stroke
- 01
Safety Alert: Thrombus Risk with Abiomed Catheter Introducer Kit
The FDA has issued an early alert regarding the Abiomed 14Fr Low Profile Introducer Kit, indicating that prolonged use may lead to thrombus formation. This issue raises significant safety concerns for patients requiring catheterisation. Clinicians should be aware of this risk when managing patients who may use this device.
via FDA MedWatch
- 02
Study Examines Ambulance Transport for Aged Care Residents
A retrospective cohort study published in the Medical Journal of Australia investigates predictors of ambulance transport to hospitals for older individuals residing in Tasmanian aged care facilities. The research aims to provide insights into the factors influencing ambulance use in this demographic. Understanding these predictors may assist healthcare professionals in managing the care of older patients. The study contributes to the growing body of knowledge regarding emergency transport needs in aged care settings.
- 03
Trial Assesses Tenecteplase Before Endovascular Treatment for Stroke
A phase 3 randomized superiority trial in China evaluated the efficacy and adverse events of administering tenecteplase prior to endovascular treatment (EVT) compared to EVT alone. The study focused on patients with ischemic stroke due to proximal middle cerebral artery occlusion, treated 4.5 to 24 hours after symptom onset. The findings could impact treatment protocols in acute stroke management.
- 04
Study Finds No Autism Risk from Acetaminophen in Pregnancy
A new study has determined that there is no association between acetaminophen use during pregnancy and an increased risk of autism. This finding is significant for healthcare providers advising pregnant patients on medication safety. The research contributes to the ongoing discussion regarding the safety of common medications during pregnancy.
via JAMA
- 05
Virtual Neurology Visits Effective for Initial Evaluations
New research indicates that virtual visits may be suitable for first-time neurology evaluations. This finding suggests that telehealth options can effectively replace in-person consultations for initial assessments in neurology. The study's results could influence how healthcare providers approach patient evaluations in this specialty.
via JAMA
- 06
Trial Compares Intra-Arterial Alteplase After Thrombectomy for Stroke
A randomized clinical trial has evaluated the effects of adjunctive intra-arterial alteplase following successful thrombectomy in patients with acute ischemic stroke. The study compares functional outcomes and cerebral reperfusion between those receiving alteplase and those undergoing thrombectomy alone. This research could influence clinical practice in stroke management.
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.